Published in Urology on May 24, 2013
Screening and monitoring in men prescribed testosterone therapy in the U.S., 2001-2010. Public Health Rep (2015) 2.09
Effects of long-term androgen replacement therapy on the physical and mental statuses of aging males with late-onset hypogonadism: a multicenter randomized controlled trial in Japan (EARTH Study). Asian J Androl (2015) 1.39
Can testosterone therapy be offered to men on active surveillance for prostate cancer? Preliminary results. Asian J Androl (2015) 0.89
Testosterone Therapy in Patients with Treated and Untreated Prostate Cancer: Impact on Oncologic Outcomes. J Urol (2016) 0.86
Testosterone Therapy in Men With Prostate Cancer. Eur Urol (2015) 0.85
Testosterone and benign prostatic hyperplasia. Asian J Androl (2015) 0.82
Testosterone therapy in men with prostate cancer: literature review, clinical experience, and recommendations. Asian J Androl (2015) 0.80
Adverse effects of testosterone replacement therapy: an update on the evidence and controversy. Ther Adv Drug Saf (2014) 0.78
Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials. J Sex Med (2016) 0.76
Outcomes of Prostate Biopsy in Men with Hypogonadism Prior or During Testosterone Replacement Therapy. Int Braz J Urol (2016) 0.75
Re: Use of testosterone replacement therapy in the United States and its effect on subsequent prostate cancer outcomes. J Urol (2013) 0.75
Testosterone Replacement Therapy and Risk of Favorable and Aggressive Prostate Cancer. J Clin Oncol (2017) 0.75
Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trials. JAMA (2011) 7.61
Marital status and survival in patients with cancer. J Clin Oncol (2013) 5.82
Cost implications of the rapid adoption of newer technologies for treating prostate cancer. J Clin Oncol (2011) 4.60
Use, costs and comparative effectiveness of robotic assisted, laparoscopic and open urological surgery. J Urol (2012) 2.94
Hospital volume, utilization, costs and outcomes of robot-assisted laparoscopic radical prostatectomy. J Urol (2012) 2.79
Comparative effectiveness of perineal versus retropubic and minimally invasive radical prostatectomy. J Urol (2010) 2.77
Economic costs of overactive bladder in the United States. Urology (2009) 2.68
Delivering high-quality and affordable care throughout the cancer care continuum. J Clin Oncol (2013) 2.39
Influence of surgeon and hospital volume on radical prostatectomy costs. J Urol (2012) 2.37
Radical retropubic prostatectomy and robotic-assisted laparoscopic prostatectomy: likelihood of positive surgical margin(s). Urology (2010) 2.31
Thermal ablation vs surgery for localized kidney cancer: a Surveillance, Epidemiology, and End Results (SEER) database analysis. Urology (2011) 2.24
Robot-assisted versus open radical prostatectomy: the differential effect of regionalization, procedure volume and operative approach. J Urol (2012) 2.22
Radical prostatectomy vs radiotherapy vs observation among older patients with clinically localized prostate cancer: a comparative effectiveness evaluation. BJU Int (2013) 2.12
Stepwise approach for nerve sparing without countertraction during robot-assisted radical prostatectomy: technique and outcomes. Eur Urol (2011) 2.09
Comparison of outpatient narcotic prescribing patterns after minimally invasive versus retropubic and perineal radical prostatectomy. J Urol (2011) 2.05
Reduced penile size and treatment regret in men with recurrent prostate cancer after surgery, radiotherapy plus androgen deprivation, or radiotherapy alone. Urology (2013) 2.04
Comparative analysis of outcomes and costs following open radical cystectomy versus robot-assisted laparoscopic radical cystectomy: results from the US Nationwide Inpatient Sample. Eur Urol (2012) 1.86
Utilization and expense of adjuvant cancer therapies following radical prostatectomy. Cancer (2011) 1.85
Which patients with undetectable PSA levels 5 years after radical prostatectomy are still at risk of recurrence?--implications for a risk-adapted follow-up strategy. Urology (2010) 1.83
Factors associated with the adoption of minimally invasive radical prostatectomy in the United States. J Urol (2012) 1.78
Temporal national trends of minimally invasive and retropubic radical prostatectomy outcomes from 2003 to 2007: results from the 100% Medicare sample. Eur Urol (2011) 1.76
Comparative effectiveness of robot-assisted and open radical prostatectomy in the postdissemination era. J Clin Oncol (2014) 1.74
Comparative effectiveness, costs and trends in treatment of small renal masses from 2005 to 2007. BJU Int (2013) 1.73
Athermal division and selective suture ligation of the dorsal vein complex during robot-assisted laparoscopic radical prostatectomy: description of technique and outcomes. Eur Urol (2010) 1.58
Trends in the care of radical prostatectomy in the United States from 2003 to 2006. BJU Int (2010) 1.57
A systematic review of the volume-outcome relationship for radical prostatectomy. Eur Urol (2013) 1.48
Quality of life, pain and return to normal activities following laparoscopic donor nephrectomy versus open mini-incision donor nephrectomy. J Urol (2003) 1.47
Technical refinement and learning curve for attenuating neurapraxia during robotic-assisted radical prostatectomy to improve sexual function. Eur Urol (2012) 1.45
Risk of all-cause and prostate cancer-specific mortality after brachytherapy in men with small prostate size. Int J Radiat Oncol Biol Phys (2010) 1.44
Lack of reduction in racial disparities in cancer-specific mortality over a 20-year period. Cancer (2014) 1.41
2008 US Preventive Services Task Force recommendations and prostate cancer screening rates. JAMA (2012) 1.41
Testosterone replacement therapy in men with prostate cancer: a time-varying analysis. J Sex Med (2014) 1.39
Randomized controlled trial of barbed polyglyconate versus polyglactin suture for robot-assisted laparoscopic prostatectomy anastomosis: technique and outcomes. Eur Urol (2010) 1.38
Recommendations for post-prostatectomy radiation therapy in the United States before and after the presentation of randomized trials. J Urol (2010) 1.29
Overuse of imaging for staging low risk prostate cancer. J Urol (2011) 1.14
Anatomic bladder neck preservation during robotic-assisted laparoscopic radical prostatectomy: description of technique and outcomes. Eur Urol (2009) 1.03
Cardiovascular comorbidity and treatment regret in men with recurrent prostate cancer. BJU Int (2011) 1.03
Overcoming the learning curve for robotic-assisted laparoscopic radical prostatectomy. Urol Clin North Am (2010) 1.03
Utilization of pharmacotherapy for erectile dysfunction following treatment for prostate cancer. J Sex Med (2010) 1.02
Influence of androgen deprivation therapy on all-cause mortality in men with high-risk prostate cancer and a history of congestive heart failure or myocardial infarction. Int J Radiat Oncol Biol Phys (2011) 1.00
Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature. Eur Urol (2012) 0.98
Inappropriate utilization of radiographic imaging in men with newly diagnosed prostate cancer in the United States. Cancer (2011) 0.97
Surgical apgar outcome score: perioperative risk assessment for radical cystectomy. J Urol (2009) 0.93
Population-based determinants of radical prostatectomy surgical margin positivity. BJU Int (2010) 0.91
Drug treatment of urological symptoms: estimating the magnitude of unmet need in a community-based sample. BJU Int (2009) 0.91
The current status of robotic oncologic surgery. CA Cancer J Clin (2012) 0.90
Stepwise description and outcomes of bladder neck sparing during robot-assisted laparoscopic radical prostatectomy. J Urol (2012) 0.90
In-hospital mortality and failure-to-rescue rates after radical cystectomy. BJU Int (2013) 0.87
National trends in hospital-acquired preventable adverse events after major cancer surgery in the USA. BMJ Open (2013) 0.87
Nerve-sparing technique and urinary control after robot-assisted laparoscopic prostatectomy. World J Urol (2010) 0.87
The impact of prostate size, median lobe, and prior benign prostatic hyperplasia intervention on robot-assisted laparoscopic prostatectomy: technique and outcomes. Eur Urol (2011) 0.86
Individual physician experience with laparoscopic supracervical hysterectomy in a single outpatient setting. Surg Innov (2007) 0.86
Variations in surgeon volume and use of pelvic lymph node dissection with open and minimally invasive radical prostatectomy. Urology (2008) 0.86
The effect of minimally invasive and open radical prostatectomy surgeon volume. Urol Oncol (2010) 0.86
Use of surveillance imaging following treatment of small renal masses. J Urol (2013) 0.85
Impact of radical prostatectomy positive surgical margins on fear of cancer recurrence: results from CaPSURE. Urol Oncol (2008) 0.85
Outcomes assessment in men undergoing open retropubic radical prostatectomy, laparoscopic radical prostatectomy, and robotic-assisted radical prostatectomy. World J Urol (2011) 0.84
Does robotic prostatectomy meet its promise in the management of prostate cancer? Curr Urol Rep (2013) 0.82
Partial clamping of the renal artery during robot-assisted laparoscopic partial nephrectomy: technique and initial outcomes. J Endourol (2012) 0.81
Current controversies and challenges in robotic-assisted, laparoscopic, and open partial nephrectomies. World J Urol (2014) 0.81
Delayed staple erosion into the bladder after removal of a benign ovarian mass. J Minim Invasive Gynecol (2009) 0.81
Posttreatment prostate specific antigen nadir predicts prostate cancer specific and all cause mortality. J Urol (2012) 0.80
Influence of Lymphadenectomy on Survival for Early-Stage Endometrial Cancer. Obstet Gynecol (2016) 0.80
Testosterone replacement therapy following the diagnosis of prostate cancer: outcomes and utilization trends. J Sex Med (2014) 0.79
Comparative effectiveness of cryotherapy vs brachytherapy for localised prostate cancer. BJU Int (2011) 0.79
Suicidal ideation in prostate cancer survivors: understanding the role of physical and psychological health outcomes. Cancer (2014) 0.79
Health care-associated infections after major cancer surgery: temporal trends, patterns of care, and effect on mortality. Cancer (2013) 0.79
Patterns of care and outcomes of radiotherapy for lymph node positivity after radical prostatectomy. BJU Int (2013) 0.79
Improved survival with single-agent paclitaxel consolidation/maintenance therapy in advanced ovarian carcinoma. Oncology (2007) 0.79
Utilization and Outcomes of Ovarian Conservation in Premenopausal Women With Endometrial Cancer. Obstet Gynecol (2016) 0.78
Landmarks for consistent nerve sparing during robotic-assisted laparoscopic radical prostatectomy. J Endourol (2008) 0.77
Video-based peer feedback through social networking for robotic surgery simulation: a multicenter randomized controlled trial. Ann Surg (2015) 0.77
Anatomic and technical considerations for optimizing recovery of sexual function during robotic-assisted radical prostatectomy. Curr Opin Urol (2013) 0.77
Population-based determinants of radical prostatectomy operative time. BJU Int (2014) 0.77
Certificate of need programs, intensity modulated radiation therapy use and the cost of prostate cancer care. J Urol (2012) 0.77
Robotic and standard open radical prostatectomy: oncological and quality-of-life outcomes. J Comp Eff Res (2013) 0.76
Racial disparities in operative outcomes after major cancer surgery in the United States. World J Surg (2015) 0.76
Morbidity and costs of salvage vs. primary radical prostatectomy in older men. Urol Oncol (2012) 0.76
Hospital surgical volume, utilization, costs and outcomes of retroperitoneal lymph node dissection for testis cancer. Adv Urol (2012) 0.75
Trends in Periodic Surveillance Testing for Early-Stage Uterine Cancer Survivors. Obstet Gynecol (2016) 0.75
Utilization and Toxicity of Alternative Delivery Methods of Adjuvant Chemotherapy for Ovarian Cancer. Obstet Gynecol (2016) 0.75
More on Reevaluating PSA Testing Rates in the PLCO Trial. N Engl J Med (2016) 0.75
Utilization and Outcomes of Chemotherapy in Women With Intermediate-Risk, Early-Stage Ovarian Cancer. Obstet Gynecol (2016) 0.75
Utilization and Outcomes of Sentinel Lymph Node Biopsy for Vulvar Cancer. Obstet Gynecol (2016) 0.75
Vouchers for Future Kidney Transplants to Overcome 'Chronological Incompatibility' Between Living Donors and Recipients. Transplantation (2017) 0.75
Identification of comorbidities that place men at highest risk of death from androgen deprivation therapy before brachytherapy for prostate cancer. Brachytherapy (2013) 0.75
Effect of minimizing tension during robotic-assisted laparoscopic radical prostatectomy on urinary function recovery. World J Urol (2012) 0.75
Robotic urethrovesical anastomosis: combining running and interrupted sutures. J Endourol (2008) 0.75
Identifying suicidal symptoms in prostate cancer survivors using brief self-report. J Cancer Surviv (2014) 0.75
Challenges of interpreting and improving radical prostatectomy outcomes: technique, technology, training, and tactical reporting. Eur Urol (2011) 0.75
Salvage robotic assisted laparoscopic radical prostatectomy: indications and outcomes. World J Urol (2010) 0.75
Why I perform robotic-assisted laparoscopic radical prostatectomy, despite more incontinence and erectile dysfunction diagnoses compared to open surgery: it's not about the robot. Eur Urol (2009) 0.75
Dilemmas and controversies in the management of prostate cancer continue to present a vexing challenge to physicians and patients dealing with the disease. Preface. Urol Clin North Am (2010) 0.75
Partial gland ablation in the management of prostate cancer: a review. Curr Opin Urol (2016) 0.75
So you want to be a robotic surgeon? Curr Opin Urol (2013) 0.75
Health services research in urology. World J Urol (2011) 0.75